EP814 TGFβ pathway activation is a predictor of progression free and overall survival in advanced high-grade serous ovarian cancer according to the surgical aggressiveness and rate of cytoreduction of different oncologic centers

L Ceppi; T Grassi; C Romualdi; P Di Lorenzo; S Palazzi; E Biagioli; A Garbi; L Paracchini; F Landoni; GD Aletti; N Colombo; R Fruscio; S Marchini; M D’Incalci

doi:10.1136/ijgc-2019-ESGO.864

Citation Tools

ePoster

EP814 TGFβ pathway activation is a predictor of progression free and overall survival in advanced high-grade serous ovarian cancer according to the surgical aggressiveness and rate of cytoreduction of different oncologic centers

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Cite this article as:: Ceppi L, Grassi T, Romualdi C, et al

EP814 TGFβ pathway activation is a predictor of progression free and overall survival in advanced high-grade serous ovarian cancer according to the surgical aggressiveness and rate of cytoreduction of different oncologic centers

International Journal of Gynecologic Cancer 2019;29:A450.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password